CYREN LTD (CYRN) Forecast, Price Target & Analyst Ratings

NASDAQ:CYRNIL0010832371

Current stock price

0.2182 USD
-0.06 (-20.65%)
At close:
0.204 USD
-0.01 (-6.51%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CYREN LTD (CYRN).

Forecast Snapshot

Consensus Price Target

Price Target
$1.53
+ 601.19% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 15, 2023

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$1.53
Upside
+ 601.19%
From current price of $0.22 to mean target of $1.53, Based on 7 analyst forecasts
Low
$1.52
Median
$1.53
High
$1.58

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for CYRN. The average price target is 1.53 USD. This implies a price increase of 601.19% is expected in the next year compared to the current price of 0.2182.

Analyst Ratings & History

Current Analyst Ratings

CYRN Current Analyst RatingCYRN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

CYRN Historical Analyst RatingsCYRN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
CYRN was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CYRN.
In the previous month the buy percentage consensus was at a similar level.
CYRN was analyzed by 7 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 15, 2023

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021
Revenue
YoY % growth
CYRN revenue by date.CYRN revenue by date.
38.39M
6.94%
36.39M
-5.21%
31.187M
-14.30%
EBITDA
YoY % growth
CYRN ebitda by date.CYRN ebitda by date.
-11.96M
9.87%
-10.57M
11.62%
-16.725M
-58.23%
EBIT
YoY % growth
CYRN ebit by date.CYRN ebit by date.
-17.67M
8.45%
-15.74M
10.92%
-21.805M
-38.53%
Operating Margin
CYRN operating margin by date.CYRN operating margin by date.
-46.03%-43.25%-69.92%
EPS
YoY % growth
CYRN eps by date.CYRN eps by date.
-5.60
3.45%
-4.40
21.43%
-4.59
-4.32%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CYRN Yearly Revenue VS EstimatesCYRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M
CYRN Yearly EPS VS EstimatesCYRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 -2 -4 -6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

CYREN LTD / CYRN Forecast FAQ

What is the price target for CYRN stock?

7 analysts have analysed CYRN and the average price target is 1.53 USD. This implies a price increase of 601.19% is expected in the next year compared to the current price of 0.2182.

When does CYREN LTD (CYRN) report earnings?

CYREN LTD (CYRN) will report earnings on 2023-05-15.

What is the consensus rating for CYREN LTD (CYRN) stock?

The consensus rating for CYREN LTD (CYRN) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.